1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Maltsev, A. Grishaev, A. Roche, J. Zasloff, M. Bax, A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Am.Chem.Soc. JACSAT 0004 0002-7863 136 3752 3755 10.1021/ja4132642 24568736 Improved cross validation of a static ubiquitin structure derived from high precision residual dipolar couplings measured in a drug-based liquid crystalline phase. 2014 10.2210/pdb2mjb/pdb pdb_00002mjb 8576.831 Ubiquitin-60S ribosomal protein L40 Ubiquitin-like 3 domain 1 man polymer CEP52, Ubiquitin A-52 residue ribosomal protein fusion product 1, Ubiquitin, 60S ribosomal protein L40, Ubiquitin-40S ribosomal protein S27a, Ubiquitin carboxyl extension protein 80, Ubiquitin, 40S ribosomal protein S27a, Polyubiquitin-B, Ubiquitin, Polyubiquitin-C, Ubiquitin no no MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample UBA52, UBCEP2, RPS27A, UBA80, UBCEP1, UBB, UBC 9606 Homo sapiens 511693 Escherichia coli BL21 PET11A database_2 pdbx_database_status pdbx_nmr_software pdbx_nmr_spectrometer repository Initial release Data collection Database references Other 1 0 2014-03-26 1 1 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model Solution nmr structure of ubiquitin refined against dipolar couplings in 2 media BMRB Y RCSB 2014-01-02 REL REL REL REL 2754 35 64 6.9 all calculated structures submitted 20 20 0.024 2D 1H-15N IPAP HSQC 2D 1H-15N IPAP HSQC 2D 1H-15N TROSY HSQC 2D 1H-15N TROSY HSQC 3D TROSY HNCO 3D TROSY HNCO 3D HN(CO)CA 1H-1H decoupled 1H-15N ARTSY 0.5 mM [U-100% 13C; U-100% 15N; U-100% 2H] 20 mM [U-100% 2H] 4.8 mM 1.5 mM 10 mM 0.5 mM [U-100% 13C; U-100% 15N; U-100% 2H] 20 mM [U-100% 2H] 1.5 mM 10 mM 0.6 mM [U-100% 13C; U-100% 15N] 13 mg/mL 140 mM 0.8 mM [U-100% 13C; U-100% 15N; U-100% 2H] 14 mg/mL 150 mM 6.0 ambient 308 K 6.0 ambient 298 K Refinement against residual dipolar couplings in 4 alignment media, distance, dihedral angle, and through-H bond (N/C) J-coupling restraints with hydrogen-bonding database potential starting from the coordinates of 1D3Z entry. simulated annealing 1 closest to the average 0.5 mM [U-100% 13C; U-100% 15N; U-100% 2H] ubiquitin, 20 mM [U-100% 2H] D4-imidazole, 4.8 mM squalamine, 1.5 mM hexanol, 10 mM sodium phosphate, 95% H2O/5% D2O 95% H2O/5% D2O 0.5 mM [U-100% 13C; U-100% 15N; U-100% 2H] ubiquitin, 20 mM [U-100% 2H] D4-imidazole, 1.5 mM hexanol, 10 mM sodium phosphate, 95% H2O/5% D2O 95% H2O/5% D2O 0.6 mM [U-100% 13C; U-100% 15N] ubiquitin, 13 mg/mL Pf1 phage, 140 mM sodium chloride, 95% H2O/5% D2O 95% H2O/5% D2O 0.8 mM [U-100% 13C; U-100% 15N; U-100% 2H] ubiquitin, 14 mg/mL Pf1 phage, 150 mM sodium chloride, 95% H2O/5% D2O 95% H2O/5% D2O Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax data analysis NMRPipe Schwieters, Kuszewski, Tjandra and Clore refinement X-PLOR NIH 500 Bruker AVANCE Bruker Avance 600 Bruker AVANCE Bruker Avance 800 Bruker AVANCE Bruker Avance MET 1 n 1 MET 1 A GLN 2 n 2 GLN 2 A ILE 3 n 3 ILE 3 A PHE 4 n 4 PHE 4 A VAL 5 n 5 VAL 5 A LYS 6 n 6 LYS 6 A THR 7 n 7 THR 7 A LEU 8 n 8 LEU 8 A THR 9 n 9 THR 9 A GLY 10 n 10 GLY 10 A LYS 11 n 11 LYS 11 A THR 12 n 12 THR 12 A ILE 13 n 13 ILE 13 A THR 14 n 14 THR 14 A LEU 15 n 15 LEU 15 A GLU 16 n 16 GLU 16 A VAL 17 n 17 VAL 17 A GLU 18 n 18 GLU 18 A PRO 19 n 19 PRO 19 A SER 20 n 20 SER 20 A ASP 21 n 21 ASP 21 A THR 22 n 22 THR 22 A ILE 23 n 23 ILE 23 A GLU 24 n 24 GLU 24 A ASN 25 n 25 ASN 25 A VAL 26 n 26 VAL 26 A LYS 27 n 27 LYS 27 A ALA 28 n 28 ALA 28 A LYS 29 n 29 LYS 29 A ILE 30 n 30 ILE 30 A GLN 31 n 31 GLN 31 A ASP 32 n 32 ASP 32 A LYS 33 n 33 LYS 33 A GLU 34 n 34 GLU 34 A GLY 35 n 35 GLY 35 A ILE 36 n 36 ILE 36 A PRO 37 n 37 PRO 37 A PRO 38 n 38 PRO 38 A ASP 39 n 39 ASP 39 A GLN 40 n 40 GLN 40 A GLN 41 n 41 GLN 41 A ARG 42 n 42 ARG 42 A LEU 43 n 43 LEU 43 A ILE 44 n 44 ILE 44 A PHE 45 n 45 PHE 45 A ALA 46 n 46 ALA 46 A GLY 47 n 47 GLY 47 A LYS 48 n 48 LYS 48 A GLN 49 n 49 GLN 49 A LEU 50 n 50 LEU 50 A GLU 51 n 51 GLU 51 A ASP 52 n 52 ASP 52 A GLY 53 n 53 GLY 53 A ARG 54 n 54 ARG 54 A THR 55 n 55 THR 55 A LEU 56 n 56 LEU 56 A SER 57 n 57 SER 57 A ASP 58 n 58 ASP 58 A TYR 59 n 59 TYR 59 A ASN 60 n 60 ASN 60 A ILE 61 n 61 ILE 61 A GLN 62 n 62 GLN 62 A LYS 63 n 63 LYS 63 A GLU 64 n 64 GLU 64 A SER 65 n 65 SER 65 A THR 66 n 66 THR 66 A LEU 67 n 67 LEU 67 A HIS 68 n 68 HIS 68 A LEU 69 n 69 LEU 69 A VAL 70 n 70 VAL 70 A LEU 71 n 71 LEU 71 A ARG 72 n 72 ARG 72 A LEU 73 n 73 LEU 73 A ARG 74 n 74 ARG 74 A GLY 75 n 75 GLY 75 A GLY 76 n 76 GLY 76 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O ILE 13 A O ILE 13 A N VAL 5 A N VAL 5 A N PHE 4 A N PHE 4 A O LEU 67 A O LEU 67 A O HIS 68 A O HIS 68 A N ILE 44 A N ILE 44 A N PHE 45 A N PHE 45 A O LYS 48 A O LYS 48 4 A ARG 74 -139.84 -54.44 12 A ARG 74 -149.35 -56.89 18 A LEU 73 -160.25 114.36 closest to the average, model1 Solution nmr structure of ubiquitin refined against dipolar couplings in 4 media 1 N N A THR 22 A THR 22 HELX_P A GLY 35 A GLY 35 1 1 14 A PRO 37 A PRO 37 HELX_P A ASP 39 A ASP 39 5 2 3 A LEU 56 A LEU 56 HELX_P A ASN 60 A ASN 60 5 3 5 SIGNALING PROTEIN RESIDUAL DIPOLAR COUPLING, SQUALAMINE, SIGNALING PROTEIN RL40_HUMAN UNP 1 153 P62987 MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIF VKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG 229 304 2MJB 1 76 P62987 A 1 1 76 5 anti-parallel parallel anti-parallel anti-parallel A THR 12 A THR 12 A GLU 16 A GLU 16 A GLN 2 A GLN 2 A LYS 6 A LYS 6 A THR 66 A THR 66 A LEU 71 A LEU 71 A GLN 41 A GLN 41 A PHE 45 A PHE 45 A LYS 48 A LYS 48 A GLN 49 A GLN 49